NASDAQ · PPCB
Propanc Biopharma, Inc.
$1.86-$0.25 (-12.08%)
Propanc Biopharma, Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.42% below the high.
Loading market information…
OTC · QTXB · USD
Stock price, earnings
Quote as of Apr 8, 2025, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
QuantRx Biomedical Corporation’s quoted price sits in the lower half of its reported 52-week range, 87.5% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow QuantRx Biomedical Corporation’s reporting calendar.
THE COMPANY BEHIND THE TICKER
QuantRx Biomedical Corporation is engaged in the creation and marketing of its patented miniature pads (PADs) and related over-the-counter (OTC) products within the United States. Additionally, the company is developing genomic diagnostic tools for the laboratory market, leveraging its proprietary lateral flow technologies, including the RapidSense single-step lateral flow test. The company's PAD products are designed to address a range of medical conditions such as hemorrhoids, mild vaginal infections, urinary incontinence, menstrual hygiene, and other general medical needs. Key offerings include InSync, an interlabial pad for feminine hygiene. Another significant product is the Unique miniform, which comes in two forms: a medicated pad providing temporary relief from the itching and discomfort associated with hemorrhoids and minor vaginal infections, and an unmedicated pad for daily management of light urinary, vaginal, or anal leakage. Other treated miniform products are also part of their portfolio. Established in 1986, QuantRx Biomedical Corporation is headquartered in Tualatin, Oregon.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 04:20 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
KEEP COMPARING
$1.86-$0.25 (-12.08%)
Propanc Biopharma, Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.42% below the high.
$0.00+$0.00 (+9,900.0%)
MedMen Enterprises Inc.: Healthcare · Drug Manufacturers - Specialty & Generic.
$0.00-$0.00 (-90.0%)
RedHawk Holdings Corp.: Healthcare · Medical - Devices.
$0.02-$0.00 (-5.0%)
Mycotopia Therapies, Inc.’s quoted price sits in the lower half of its reported 52-week range, 89.44% below the high.
$0.00+$0.00 (+29,900.0%)
Miravant Medical Technologies Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.03$0.00 (0.0%)
TRACON Pharmaceuticals, Inc.’s quoted price sits in the lower half of its reported 52-week range, 95.7% below the high.
$0.00-$0.05 (-99.6%)
StatSure Diagnostic Systems, Inc.: Healthcare · Medical - Devices.
$0.00$0.00 (0.0%)
PotNetwork Holdings, Inc.: Healthcare · Drug Manufacturers - Specialty & Generic.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
